Every 10-Q that Cemtrex (CETX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CETX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CETX filings page.
Cemtrex, Inc. reported results for the quarter and nine months ended June 30, 2026, showing a larger balance sheet driven by acquisitions but continued significant losses and financing costs. Total assets were $70.0 million versus $47.8 million at September 30, 2025, with stockholders’ equity increasing to $32.0 million.
Revenue for the nine months was $52.6 million (Security $17.5 million, Industrial Services $31.6 million, Aerospace and Defense $3.4 million). The company recorded a nine‑month net loss of $24.1 million and used $4.9 million of cash in operating activities, driven by high $13.8 million interest expense and warrant‑related items.
Cemtrex completed the cash acquisition of Invocon (Aerospace and Defense segment) with $6.7 million consideration and the Richland asset and facility acquisition in Industrial Services with $5.4 million consideration, including a bargain purchase gain of $2.1 million. Cash, cash equivalents and restricted cash rose to $9.3 million, supported by $10.0 million of equity offerings and $5.8 million of warrant exercises. Management nonetheless states that recurring losses and $10.4 million of debt obligations over the next fiscal year raise substantial doubt about Cemtrex’s ability to continue as a going concern.
Cemtrex, Inc. reported results for the quarter ended March 31, 2026 with revenue of $18.1 million, down from $27.3 million a year earlier, but posted net income attributable to stockholders of $907,048, largely influenced by non‑operating items.
For the first six months of fiscal 2026, revenue was $34.2 million versus $41.0 million in the prior‑year period, and Cemtrex recorded a net loss of $19.6 million. Cash used in operating activities was $5.3 million, while financing activities provided $20.9 million, including a $10.0 million equity offering and warrant exercises.
The company completed two acquisitions: Invocon, Inc. for cash consideration of $7.06 million (recognizing $3.98 million of goodwill and $3.13 million of intangible assets) and the assets of Richland Industries LLC with total preliminary consideration of $5.44 million and a recorded bargain purchase gain of $2.07 million.
Despite ending the quarter with $7.9 million in cash, cash equivalents and restricted cash and total assets of $70.7 million, management disclosed that recurring large net losses, including $28.1 million in fiscal 2025 and substantial debt obligations of $10.8 million due over the next fiscal year, raise substantial doubt about Cemtrex’s ability to continue as a going concern.
Cemtrex, Inc. reported a larger-than-normal quarterly loss despite higher sales. For the three months ended December 31, 2025, revenue rose to $16.1 million from $13.7 million, but net loss was still $20.6 million, driven mainly by $12.1 million of interest expense and $4.7 million of warrant-related losses.
Cash and cash equivalents increased sharply to $20.5 million, helped by $5.7 million of warrant exercises, $6.0 million of equity offerings, and a $7.0 million note. Common shares outstanding jumped to 8.6 million at December 31, 2025, and 10.1 million by February 13, 2026, reflecting significant dilution.
Management explicitly states that recurring losses of $28.1 million in fiscal 2025, a $20.6 million quarterly loss, and $6.7 million of debt due within a year raise substantial doubt about Cemtrex’s ability to continue as a going concern. Subsequent to quarter-end, Cemtrex completed a $7.06 million cash acquisition of Invocon and a Tennessee industrial services acquisition funded with new bank debt and a $4.9 million mortgage.